We also found that AXL knockdown significantly reduced the expression of the M2 macrophage marker CD206 (MRC1), CD163 and ARG1, indicating that AXL inhibits the differentiation of macrophages into M2-type macrophages, thereby suppressing ccRCC progression. The gene discussed is CD163; the disease is nonpapillary renal cell carcinoma.